Merck (MRK) rallies after FDA drug approval. Kevin Green discusses this as Merck receives FDA approval for drug Winrevair to treat pulmonary arterial hypertension. Green also goes over how Moderna (MRNA) is trading higher after a $750M investment in flu research. Tune in to find out more about the stock market today.
#investing #trading #finance #stocks #global #equities #markets #stockmarket #stockmarkettoday #merck #moderna #healthcare
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - [ Ссылка ]
Download the iOS app - [ Ссылка ]
Download the Amazon Fire Tv App - [ Ссылка ]
Watch on Sling - [ Ссылка ]
Watch on Vizio - [ Ссылка ]
Watch on DistroTV - [ Ссылка ]
Follow us on X – [ Ссылка ]
Follow us on Facebook – [ Ссылка ]
Follow us on LinkedIn - [ Ссылка ]
About Schwab Network - [ Ссылка ]
